famotidine has been researched along with Hypertension, Portal in 1 studies
Famotidine: A competitive histamine H2-receptor antagonist. Its main pharmacodynamic effect is the inhibition of gastric secretion.
Hypertension, Portal: Abnormal increase of resistance to blood flow within the hepatic PORTAL SYSTEM, frequently seen in LIVER CIRRHOSIS and conditions with obstruction of the PORTAL VEIN.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Crespi, C | 1 |
| De Giorgio, AM | 1 |
1 other study available for famotidine and Hypertension, Portal
| Article | Year |
|---|---|
[Association of biliary calculosis and portal cavernomatosis].
Topics: Cholangiography; Cholelithiasis; Famotidine; Female; Follow-Up Studies; Hemangioma, Cavernous; Human | 1992 |